Tigikwik Injection
Marketer
Nurtureplus Biotech Private Limited
Salt Composition
Tigecycline (50mg)
Overview Tigikwik Injection
KwikTreat Injection is a bactericidal antibiotic indicated for serious bacterial infections. Its applications include severe skin infections, intra-abdominal sepsis, and community-acquired pneumonia. The drug's mechanism involves direct bacterial cell death. It's ineffective against viral pathogens. KwikTreat Injection is frequently administered to hospitalized patients requiring critical care, delivered intravenously either by infusion or direct injection under medical supervision. Dosage is individualized based on infection type, location, and severity. Consistent daily administration is crucial for optimal efficacy; complete the prescribed course, even with rapid symptom improvement, to prevent relapse or worsening of infection. Potential side effects, such as headache, nausea, vomiting, elevated liver enzymes, abdominal discomfort, and diarrhea, are typically transient and resolve with continued therapy. Report persistent or bothersome side effects to your physician. Dizziness is possible; avoid activities requiring alertness. Prior to initiation, inform your doctor of pregnancy, breastfeeding, liver conditions, or antibiotic allergies. Regular blood tests to monitor liver function may be recommended during treatment.
Primary Ingredients of Tigikwik Injection
No text was provided to rewrite. Please provide the text you wish to have rephrased.
Uses of Tigikwik Injection
Life-threatening bacterial infections
Major Benefits of Tigikwik Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Tigikwik Injection:
- Headache
- Vomiting
- Nausea
- Increased liver enzymes
- Stomach pain
- Diarrhea
How to use Tigikwik Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Tigikwik Injection works:
Tigikwik Injection, an antibacterial agent, inhibits bacterial proliferation by disrupting the synthesis of vital proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Tigikwik Injection may be used concurrently with alcohol without reported adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Tigikwik Injection during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Administration of Tigikwik Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administration of Tigikwik Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Tigikwik Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
For patients exhibiting severe hepatic impairment, Tigikwik Injection requires careful administration. Dosage modification of Tigikwik Injection may be necessary. Physician consultation is advised.
What if you forget to take Tigikwik Injection :
Omit a Tigikwik Injection dose? Seek your physician's advice.
Facts to Know About Tigikwik Injection
| Label | Value |
|---|---|
| Chemical Type | Tetracycline antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Behavioral Class | Tetracycline antibiotics |






